Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Refractive Error and Visual Function in Children Under Non-cycloplegic Screening Conditions.

Journal of primary care & community health·2026

Same author

Effectiveness of Low-Dose Atropine for Myopia Control in European Children: A Real-World Cohort Study.

Journal of clinical medicine·2026

Same author

Exploring Visual Discrimination and Performance Adaptation in First-League Futsal Players via LUMMICS.

Vision (Basel, Switzerland)·2026

Same author

Dose-Dependent Effects of Atropine on Accommodative and Binocular Visual Function for Myopia Control in Children: A Systematic Review and Meta-Analysis.

Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)·2026

Same author

Agreement Between Non-Cycloplegic Photorefraction and Retinoscopy in Pediatric Refraction.

Life (Basel, Switzerland)·2026

Same author

Virtual Reality Orthoptic Interventions for Binocular Vision Disorders: A Systematic Review and Meta-Analysis.

Journal of eye movement research·2026

Search research articles

Related Experiment Video

Updated: Jan 7, 2026

Inducement and Evaluation of a Murine Model of Experimental Myopia

Inducement and Evaluation of a Murine Model of Experimental Myopia

Published on: January 22, 2019

Analysing myopia in Europe: A comprehensive meta-analysis.

Clara Martinez-Perez¹, Cristina Alvarez-Peregrina², Cesar Villa-Collar³

¹ISEC LISBOA - Instituto Superior de Educação e Ciências, 1750-179, Lisbon, Portugal.

Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie

|December 20, 2025

Summary

This summary is machine-generated.

Myopia affects approximately one in four Europeans, with prevalence varying significantly by age and region. This meta-analysis highlights the need for standardized myopia diagnostics and targeted public health interventions across Europe.

Keywords:

Adolescents Cycloplegia Epidemiology Europe Myopia Prevalence Public health Urbanization

More Related Videos

Binocular Dynamic Visual Acuity in Eyeglass-Corrected Myopic Patients

Binocular Dynamic Visual Acuity in Eyeglass-Corrected Myopic Patients

Published on: March 29, 2022

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model

Published on: April 3, 2016

Related Experiment Videos

Last Updated: Jan 7, 2026

Inducement and Evaluation of a Murine Model of Experimental Myopia

Inducement and Evaluation of a Murine Model of Experimental Myopia

Published on: January 22, 2019

Binocular Dynamic Visual Acuity in Eyeglass-Corrected Myopic Patients

Binocular Dynamic Visual Acuity in Eyeglass-Corrected Myopic Patients

Published on: March 29, 2022

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model

Published on: April 3, 2016

Area of Science:

Ophthalmology
Public Health
Epidemiology

Background:

Myopia (nearsightedness) is a growing global health concern.
Understanding its prevalence and risk factors in diverse populations is crucial for effective public health strategies.

Purpose of the Study:

To estimate the overall prevalence of myopia in European populations.
To analyze variations in myopia prevalence based on age, geographic region, gender, cycloplegic status, and urbanization.

Main Methods:

A meta-analysis of 28 cross-sectional observational studies involving 347,651 individuals across Europe.
Systematic literature searches in PubMed, Web of Science, and Scopus.
Meta-analytical techniques including pooled prevalence estimation, subgroup analyses, and heterogeneity assessment.

Main Results:

The overall pooled prevalence of myopia in Europe was 24.88%, with substantial heterogeneity (I²=100%).
Prevalence varied significantly by age (3.3% in children to 49.7% in adolescents) and region.
High myopia (SE ≤ -6.0 D) prevalence was 3.09%.

Conclusions:

Myopia prevalence in Europe is substantial, affecting roughly one in four individuals, particularly adolescents.
Significant variability exists between studies, influenced by environmental and methodological factors.
Standardized diagnostic criteria and targeted public health measures are essential to address the increasing burden of myopia.